Pulmonary outcome and its correlates in school-aged children born with a gestational age ≤ 32 weeks

Summary Background There is limited data regarding factors influencing the respiratory outcome at school age of ex-preterms born since the introduction of antenatal steroids, surfactant replacement together with less aggressive ventilation. Objectives To establish the main antenatal, neonatal and ea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiratory medicine 2013-12, Vol.107 (12), p.1966-1976
Hauptverfasser: Choukroun, Marie-Luce, Feghali, Hala, Vautrat, Sandrine, Marquant, Fabienne, Nacka, Fabienne, Leroy, Valériane, Demarquez, Jean- Louis, Fayon, Michaël J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Background There is limited data regarding factors influencing the respiratory outcome at school age of ex-preterms born since the introduction of antenatal steroids, surfactant replacement together with less aggressive ventilation. Objectives To establish the main antenatal, neonatal and early childhood respiratory correlates of respiratory status in school-aged children born at ≤32weeks of gestation. Methods Ex-preterm children born at ≤32weeks of gestation between 1997 and 2001 at Bordeaux University Hospital were evaluated at school age, using a respiratory questionnaire and lung function tests (spirometry, plethysmography, exercise challenge test and CO lung diffusing capacity DLCO measurements). Factors associated with lung function were investigated using polynomial regression analyses. Results Of the 151 included children [mean age: 8.6 ± 0.8 years; mean gestational age, 30.1 ± 1.7 weeks; mean birth weight = 1310 ± 380 g; 68.2% ventilated at birth; 46.4% treated with surfactant; 36.4% with prior bronchopulmonary dysplasia (BPD)], 47% presented obstructive lung abnormalities, 11% restrictive or mixed lung abnormalities, 41% exercise-induced bronchoconstriction, and 15.5% reduced DLCO. Surfactant therapy was independently associated with a lower risk of lung abnormalities ( p  
ISSN:0954-6111
1532-3064
DOI:10.1016/j.rmed.2013.06.020